Antimicrobial Stewardship, Vol 2. Developments in Emerging and Existing Infectious Diseases

  • ID: 4080955
  • Book
  • 394 Pages
  • Elsevier Science and Technology
1 of 4

Antimicrobial Stewardship (AMS), Volume Two includes the experience of ESGAP workshops and courses on antibiotic stewardship since 2012. It combines clinical and laboratory information about AMS, with a focus on human medicine.

The ESCMID study group on antibiotic policies (ESGAP) is one of the most productive groups in the field, organizing courses and workshops. This book is an ideal tool for the participants of these workshops.

With short chapters (around 1500 words) written on different topics, the authors insisted on the following points: A 'hands on', practical approach,  tips to increase success, a description of the most common mistakes, a global picture (out- and inpatient settings, all countries) and a short list of 10-20 landmark references.

  • Focuses on the most recent antimicrobial stewardship strategies
  • Provides a detailed description of laboratory support
  • Offers a balanced synthesis of basic and clinical sciences for each individual case, presenting clinical courses of the cases in parallel with the pathogenesis and detailed microbiological information for each infection
  • Describes the prevalence and incidence of the global issues and current therapeutic approaches
  • Presents the measures for infection control
Note: Product cover images may vary from those shown
2 of 4

Section A: The Global Picture of Antimicrobial Use and Resistance 1. The Global Crisis of Antimicrobial Resistance 2. Antimicrobial Stewardship: Efficacy and Implementation of Strategies to Address Antimicrobial Overuse and Resistance 3. Quality Indicators and Quantity Metrics of Antibiotic Use

Section B: AMS Strategies 4. Improving Antimicrobial Prescribing: Input from Behavioral Strategies and Quality Improvement Methods 5. Education of Healthcare Professionals on Responsible Antimicrobial Prescribing 6. Rapid Diagnostics and Biomarkers for Antimicrobial Stewardship 7. Pharmacokinetic and Pharmacodynamic Tools to Increase Efficacy 8. The Use of Computerized Decision Support Systems to Support Antimicrobial Stewardship Programs 9. The Role of Microbiology Laboratory in Promoting Antimicrobial Stewardship 10. The Role of Pharmacists 11. The Roles of Nurses in Antimicrobial Stewardship 12. Antifungal Stewardship

Section C: AMS in Specific Clinical Settings 13. Optimising Prescribing for Acute Respiratory Tract Infections as an Example for Antimicrobial Stewardship in Primary Care 14. Antimicrobial Stewardship: What to Tell the Patients and the General Public 15. Antimicrobial Stewardship in Long-Term Care Facilities 16. Antimicrobial Stewardship in ICU 17. Antimicrobial Stewardship in Hematology Patients 18. AMS in an Era of Multidrug-Resistant Bacteria

Section D: AMS Experiences Around the World 19.1: AMS Initiatives and Policies: The International Picture 19.2: Missions and Objectives of EUCIC and ESGAP 19.3: Antimicrobial Stewardship in Latin America 19.4: Antimicrobial Stewardship in Australia 19.5: Antimicrobial Stewardship in Austria 19.6: Antimicrobial Stewardship in Belgium 19.7: Antimicrobial Stewardship in Bulgaria 19.8: Antimicrobial Stewardship in Croatia 19.9: Antimicrobial Stewardship in England 19.10: Antimicrobial Stewardship in France 19.11: Antimicrobial Stewardship in Germany 19.12: Antimicrobial Stewardship in Greece 19.13: Antimicrobial Stewardship in India 19.14: Antimicrobial Stewardship in Israel 19.15: Antimicrobial Stewardship in Italy 19.16: Antimicrobial Stewardship in Japan 19.17: Antibiotic Stewardship in the Netherlands 19.18: Antimicrobial Stewardship in Scotland 19.19: Antimicrobial Stewardship in Slovenia 19.20: Antimicrobial Stewardship in South Africa 19.21: Antimicrobial Stewardship in Argentina 19.22: Antimicrobial Stewardship in Spain 19.23: Antibiotic Stewardship in Sweden 19.24: Antimicrobial Stewardship in Switzerland 19.25: Antimicrobial Stewardship in Turkey 19.26: Antimicrobial Stewardship in the United States

Section E: Research and Perspectives 20. Methodological Challenges in Evaluating Antimicrobial Stewardship Programs: "Through Measuring to Knowledge"

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Pulcini, Céline
Céline Pulcini is Full Professor of Infectious Disease in Nancy, France. Her main research interest lies in antimicrobial stewardship and vaccination practices with the aim of preventing the emergence of bacterial resistance to antibiotics.

Professor Pulcini is Secretary of ESGAP, the European Society for Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Antibiotic Policies. She is or has recently served also as Expert for the National Antibiotic Plan of the French Ministry of Health, the ECDC and the WHO. She is a member of the Executive Committee of the French Infectious Diseases Society (SPILF) and she coordinates the SPILF Antimicrobial Stewardship working group. In addition to this, Professor Pulcini is a partner in the European Innovative Medicines Initiative project 'DRIVE-AB'.

As well as serving as an Associate Editor for the journal Clinical Microbiology and Infection, Professor Pulcini has also authored or co-authored over 130 international publications. She received in 2017 the ESCMID Young Investigator Award.
Ergonul, Onder
Onder Ergonul, MD, MPH has been a professor of Infectious Diseases and Clinical Microbiology at Koç University, School of Medicine since 2011. He graduated from Hacettepe University School of Medicine in 1989 and completed his residency in 1996 in the Infectious Diseases and Clinical Microbiology department of Ankara University in Ankara, Turkey. He received his Master of Public Health degree from Harvard University School of Public Health in 2003. In 2000-2002, he worked as a research fellow in the Clinical Epidemiology division of the Infectious Diseases Department at the University of Utah, School of Medicine, USA. He is the editor of a book on Crimean-Congo Hemorrhagic Fever (2007, Springer). He received the Public Health Scientific award of Turkish Medical Association in 2007. He has been the president of the Turkish Society of Clinical Microbiology and Infectious Diseases since 2013. He has been the associate editor of Clinical Microbiology and Infection, official journal of the European Society of Clinical Microbiology and Infectious Diseases since 2013. He was elected as the member of Science Academy of Turkey in 2013.
Can, Füsun
Beovic, Bojana
Prof. Bojana Beovic, MD, PhD graduated at Medical School University in Ljubljana where she obtained her master degree and PhD. She was further educated in pharmacology at the University of Zagreb, Croatia and at The University of Wisconsin Hospital and Clinics.

From 2006 to 2009 she was the president of the Health Council at the Ministry of Health of Slovenia. From 2012 to 2017, she was the President of the Educational Council at the Medical Chamber of Slovenia. Currently, she is the head of the ID Consultancy Service at UMC Ljubljana, and vice chair of the Department of Infectious Diseases. Since 2004 she is the president of the Slovenian Society of Chemotherapy and since 2005 the vice-president of the Intersectoral Coordination Mechanism for Prudent Use of Antimicrobials at the Ministry of Health. Since 2008 she is the head of the Antibiotic Committee in UMC Ljubljana. Since 2015 she is the chair of the European Society of Clinical Microbiology and Infectious diseases (ESCMID) Study group for Antibiotic policies (ESGAP). She actively participates in several European level initiatives in the field of antimicrobial resistance and stewardship.

She is full professor of infectious diseases at the Medical School, University of Ljubljana. She was the organizer and co-organizer of several international and national scientific meetings and educational courses, and the author of several national antimicrobial guidelines and handbooks on antimicrobial therapy. Her current focus of interest in research is antibiotic stewardship, infections in surgery, and infections with multiple resistant bacteria.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll